Our statement on anti-depressant blood test study
Today, Kings College London announced that they have developed a blood test that ‘accurately and reliably’ predicts whether individuals living with depression would respond to common antidepressants, saying it could ‘herald a new era of personalised treatment for people with depression’.
Responding, Jenny Edwards CBE, Chief Executive of the Mental Health Foundation said:
“We have long been saying that medication is only a small part of the answer in treating mental health problems, there needs to be a much greater focus on providing patients with a wide range of treatments as part of a personalised approach to treatment.
“Knowing whether someone is likely to respond to medication or not will enable doctors to signpost effective treatments not involving drugs, like talking therapy and/or mindfulness, as soon as possible.
“If this test is as comprehensive and effective as thought then today’s news could mark a real sea-change in treatment, providing doctors with a new tool facilitating a more personalised approach to treatment, and moving people away from medication that doesn’t work for them or that may have risks of side effects.”